Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a82efb76e0e40579a53168c121554d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4a82efb76e0e40579a53168c121554d8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4a82efb76e0e40579a53168c121554d82021-12-02T14:17:19ZEnhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer10.1038/s41598-021-87283-y2045-2322https://doaj.org/article/4a82efb76e0e40579a53168c121554d82021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87283-yhttps://doaj.org/toc/2045-2322Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted treatment option, herein, we hypothesized that a combination of Andrographis paniculata and Oligomeric Proanthocyanidins (OPCs) might interact together with regard to anti-tumorigenic activity in CRC. As a result, we demonstrated the enhanced anti-cancer activity between these two botanical extracts in terms of their ability to inhibit cancer cell growth, suppress colony formation and induce apoptosis. Furthermore, we validated these findings in subcutaneous xenograft model and in patient derived primary epithelial 3D organoids. Transcriptomic profiling identified involvement of metabolic pathways and ferroptosis-associated genes, including HMOX1, GCLC and GCLM, that may be responsible for the increased anti-tumorigenic activity by the two compounds. Collectively, our study provides novel evidence in support of the combinatorial use of andrographis and OPCs as a potential therapeutic option, perhaps as an adjunctive treatment to classical drugs, in patients with colorectal cancer.Tadanobu ShimuraPriyanka SharmaGeeta G. SharmaJasjit K. BanwaitAjay GoelNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tadanobu Shimura Priyanka Sharma Geeta G. Sharma Jasjit K. Banwait Ajay Goel Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
description |
Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted treatment option, herein, we hypothesized that a combination of Andrographis paniculata and Oligomeric Proanthocyanidins (OPCs) might interact together with regard to anti-tumorigenic activity in CRC. As a result, we demonstrated the enhanced anti-cancer activity between these two botanical extracts in terms of their ability to inhibit cancer cell growth, suppress colony formation and induce apoptosis. Furthermore, we validated these findings in subcutaneous xenograft model and in patient derived primary epithelial 3D organoids. Transcriptomic profiling identified involvement of metabolic pathways and ferroptosis-associated genes, including HMOX1, GCLC and GCLM, that may be responsible for the increased anti-tumorigenic activity by the two compounds. Collectively, our study provides novel evidence in support of the combinatorial use of andrographis and OPCs as a potential therapeutic option, perhaps as an adjunctive treatment to classical drugs, in patients with colorectal cancer. |
format |
article |
author |
Tadanobu Shimura Priyanka Sharma Geeta G. Sharma Jasjit K. Banwait Ajay Goel |
author_facet |
Tadanobu Shimura Priyanka Sharma Geeta G. Sharma Jasjit K. Banwait Ajay Goel |
author_sort |
Tadanobu Shimura |
title |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
title_short |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
title_full |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
title_fullStr |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
title_full_unstemmed |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
title_sort |
enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/4a82efb76e0e40579a53168c121554d8 |
work_keys_str_mv |
AT tadanobushimura enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer AT priyankasharma enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer AT geetagsharma enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer AT jasjitkbanwait enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer AT ajaygoel enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer |
_version_ |
1718391603791396864 |